Early-Stage Resource Hub Calendar

This webinar will help BIO 2024 attendees/exhibitors better prepare for their onsite experience at the event. We will provide important and practical onsite information, as well as provide further instruction on how to more effectively use advanced features of the BIO One-on-One Partnering™ system.

Attend this webinar—led by BIO’s VP of Partnering and BIO’s Manager of Exhibit Sales & Systems—to gain valuable insights to make the most out of your participation at the upcoming BIO International Convention in San Diego this June!

Speakers:

• Mackensie Vernetti, Vice President, Partnering, BIO
• Sydney Williams, Manager, Exhibit Sales & Systems, BIO

The Committee concentrates on tax, financial services, securities, and accounting policies that impact member companies and biotech capital formation. This committee advises BIO staff about the impact of legislation and regulations affecting these policy matters and supports BIO’s engagement with Treasury, the SEC, and the IRS, as well as Congress and the Administration.

For more information and to join the Committee, please contact Emily Berst (eberst@bio.org).

BIO 2024 is heading back West to San Diego, CA at the San Diego Convention Center. We're looking forward to being back together in June!

Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.

Find potential business partners and request meetings through our easy-to-use online system. You can expect to find senior biotech executives, business development leaders, and investors from premier firms participating.

BIO 2024 is heading back West to San Diego, CA at the San Diego Convention Center. We're looking forward to being back together in June!

Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.

Find potential business partners and request meetings through our easy-to-use online system. You can expect to find senior biotech executives, business development leaders, and investors from premier firms participating.

BIO 2024 is heading back West to San Diego, CA at the San Diego Convention Center. We're looking forward to being back together in June!

Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.

Find potential business partners and request meetings through our easy-to-use online system. You can expect to find senior biotech executives, business development leaders, and investors from premier firms participating.

BIO 2024 is heading back West to San Diego, CA at the San Diego Convention Center. We're looking forward to being back together in June!

Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.

Find potential business partners and request meetings through our easy-to-use online system. You can expect to find senior biotech executives, business development leaders, and investors from premier firms participating.

The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics. 

For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).

The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics. 

For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).

The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics. 

For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).